nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentosan Polysulfate—FGF1—nerve—acquired immunodeficiency syndrome	0.026	0.127	CbGeAlD
Pentosan Polysulfate—FGF1—endothelium—acquired immunodeficiency syndrome	0.0221	0.108	CbGeAlD
Pentosan Polysulfate—FGF4—nervous system—acquired immunodeficiency syndrome	0.0221	0.108	CbGeAlD
Pentosan Polysulfate—FGF1—blood plasma—acquired immunodeficiency syndrome	0.0196	0.096	CbGeAlD
Pentosan Polysulfate—FGF1—retina—acquired immunodeficiency syndrome	0.0108	0.0526	CbGeAlD
Pentosan Polysulfate—FGF1—skin of body—acquired immunodeficiency syndrome	0.00944	0.0462	CbGeAlD
Pentosan Polysulfate—FGF2—spinal cord—acquired immunodeficiency syndrome	0.00932	0.0456	CbGeAlD
Pentosan Polysulfate—FGF2—vagina—acquired immunodeficiency syndrome	0.00897	0.0439	CbGeAlD
Pentosan Polysulfate—FGF2—lung—acquired immunodeficiency syndrome	0.00848	0.0415	CbGeAlD
Pentosan Polysulfate—FGF1—lymphoid tissue—acquired immunodeficiency syndrome	0.00765	0.0374	CbGeAlD
Pentosan Polysulfate—FGF1—digestive system—acquired immunodeficiency syndrome	0.00755	0.0369	CbGeAlD
Pentosan Polysulfate—FGF1—blood—acquired immunodeficiency syndrome	0.0072	0.0352	CbGeAlD
Pentosan Polysulfate—FGF1—spinal cord—acquired immunodeficiency syndrome	0.00693	0.0339	CbGeAlD
Pentosan Polysulfate—FGF1—lung—acquired immunodeficiency syndrome	0.00631	0.0308	CbGeAlD
Pentosan Polysulfate—FGF2—brain—acquired immunodeficiency syndrome	0.006	0.0294	CbGeAlD
Pentosan Polysulfate—FGF1—nervous system—acquired immunodeficiency syndrome	0.00584	0.0286	CbGeAlD
Pentosan Polysulfate—FGF2—lymph node—acquired immunodeficiency syndrome	0.0058	0.0284	CbGeAlD
Pentosan Polysulfate—FGF1—central nervous system—acquired immunodeficiency syndrome	0.00562	0.0275	CbGeAlD
Pentosan Polysulfate—FGF2—Syndecan-4-mediated signaling events—CXCR4—acquired immunodeficiency syndrome	0.00449	0.039	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Syndecan-4-mediated signaling events—CXCL12—acquired immunodeficiency syndrome	0.00449	0.039	CbGpPWpGaD
Pentosan Polysulfate—FGF1—brain—acquired immunodeficiency syndrome	0.00447	0.0218	CbGeAlD
Pentosan Polysulfate—FGF1—lymph node—acquired immunodeficiency syndrome	0.00431	0.0211	CbGeAlD
Pentosan Polysulfate—FGF4—Regulation of Actin Cytoskeleton—ACTG1—acquired immunodeficiency syndrome	0.00374	0.0325	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Syndecan-4-mediated signaling events—CCL5—acquired immunodeficiency syndrome	0.00341	0.0297	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Cardiac Progenitor Differentiation—CXCR4—acquired immunodeficiency syndrome	0.003	0.0261	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Regulation of Actin Cytoskeleton—ACTG1—acquired immunodeficiency syndrome	0.00237	0.0206	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by ERBB4—CXCL12—acquired immunodeficiency syndrome	0.00223	0.0194	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Regulation of Actin Cytoskeleton—ACTG1—acquired immunodeficiency syndrome	0.00216	0.0188	CbGpPWpGaD
Pentosan Polysulfate—FGF4—B Cell Activation—CD79A—acquired immunodeficiency syndrome	0.0017	0.0148	CbGpPWpGaD
Pentosan Polysulfate—FGF4—DAP12 interactions—HLA-B—acquired immunodeficiency syndrome	0.00142	0.0124	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by ERBB4—CXCL12—acquired immunodeficiency syndrome	0.00141	0.0123	CbGpPWpGaD
Pentosan Polysulfate—FGF4—FRS2-mediated cascade—IL6—acquired immunodeficiency syndrome	0.0014	0.0122	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Differentiation Pathway—IL6—acquired immunodeficiency syndrome	0.0013	0.0113	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by ERBB4—CXCL12—acquired immunodeficiency syndrome	0.00129	0.0112	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—ACTG1—acquired immunodeficiency syndrome	0.00126	0.011	CbGpPWpGaD
Pentosan Polysulfate—FGF1—B Cell Activation—CD79A—acquired immunodeficiency syndrome	0.00108	0.00937	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—MBL2—acquired immunodeficiency syndrome	0.00104	0.00905	CbGpPWpGaD
Pentosan Polysulfate—FGF2—B Cell Activation—CD79A—acquired immunodeficiency syndrome	0.000982	0.00855	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—APOBEC3G—acquired immunodeficiency syndrome	0.000923	0.00803	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000907	0.00789	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Angiopoietin receptor Tie2-mediated signaling—TNF—acquired immunodeficiency syndrome	0.000905	0.00788	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 interactions—HLA-B—acquired immunodeficiency syndrome	0.000903	0.00785	CbGpPWpGaD
Pentosan Polysulfate—FGF1—FRS2-mediated cascade—IL6—acquired immunodeficiency syndrome	0.000887	0.00772	CbGpPWpGaD
Pentosan Polysulfate—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.000863	0.00127	CcSEcCtD
Pentosan Polysulfate—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000861	0.00127	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.000859	0.00126	CcSEcCtD
Pentosan Polysulfate—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000854	0.00125	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.000854	0.00125	CcSEcCtD
Pentosan Polysulfate—Myalgia—Efavirenz—acquired immunodeficiency syndrome	0.000854	0.00125	CcSEcCtD
Pentosan Polysulfate—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000854	0.00125	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000853	0.00125	CcSEcCtD
Pentosan Polysulfate—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000851	0.00125	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00085	0.00125	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000849	0.00125	CcSEcCtD
Pentosan Polysulfate—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000848	0.00125	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.000848	0.00125	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000847	0.00124	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000845	0.00124	CcSEcCtD
Pentosan Polysulfate—Discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000844	0.00124	CcSEcCtD
Pentosan Polysulfate—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.000843	0.00124	CcSEcCtD
Pentosan Polysulfate—Flatulence—Saquinavir—acquired immunodeficiency syndrome	0.000842	0.00124	CcSEcCtD
Pentosan Polysulfate—FGF2—Cardiac Hypertrophic Response—TNF—acquired immunodeficiency syndrome	0.000839	0.0073	CbGpPWpGaD
Pentosan Polysulfate—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000839	0.00123	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.000838	0.00123	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.000837	0.00123	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000835	0.00123	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000831	0.00122	CcSEcCtD
Pentosan Polysulfate—FGF2—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	0.000829	0.00722	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Differentiation Pathway—IL6—acquired immunodeficiency syndrome	0.000828	0.0072	CbGpPWpGaD
Pentosan Polysulfate—Alopecia—Lamivudine—acquired immunodeficiency syndrome	0.000827	0.00122	CcSEcCtD
Pentosan Polysulfate—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000826	0.00121	CcSEcCtD
Pentosan Polysulfate—FGF4—IRS-mediated signalling—IL6—acquired immunodeficiency syndrome	0.000826	0.00719	CbGpPWpGaD
Pentosan Polysulfate—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	0.000823	0.00121	CcSEcCtD
Pentosan Polysulfate—FGF2—DAP12 interactions—HLA-B—acquired immunodeficiency syndrome	0.000823	0.00716	CbGpPWpGaD
Pentosan Polysulfate—Anaemia—Ritonavir—acquired immunodeficiency syndrome	0.00082	0.00121	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.00082	0.0012	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000818	0.0012	CcSEcCtD
Pentosan Polysulfate—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.000817	0.0012	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.000817	0.0012	CcSEcCtD
Pentosan Polysulfate—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.000816	0.0012	CcSEcCtD
Pentosan Polysulfate—FGF4—Innate Immune System—CCR2—acquired immunodeficiency syndrome	0.000815	0.00709	CbGpPWpGaD
Pentosan Polysulfate—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.00081	0.00119	CcSEcCtD
Pentosan Polysulfate—FGF2—FRS2-mediated cascade—IL6—acquired immunodeficiency syndrome	0.000809	0.00704	CbGpPWpGaD
Pentosan Polysulfate—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000807	0.00119	CcSEcCtD
Pentosan Polysulfate—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000804	0.00118	CcSEcCtD
Pentosan Polysulfate—FGF4—IRS-related events—IL6—acquired immunodeficiency syndrome	0.000803	0.00699	CbGpPWpGaD
Pentosan Polysulfate—Flatulence—Lamivudine—acquired immunodeficiency syndrome	0.000803	0.00118	CcSEcCtD
Pentosan Polysulfate—FGF1—Innate Immune System—ACTG1—acquired immunodeficiency syndrome	0.000803	0.00699	CbGpPWpGaD
Pentosan Polysulfate—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000801	0.00118	CcSEcCtD
Pentosan Polysulfate—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.0008	0.00118	CcSEcCtD
Pentosan Polysulfate—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000797	0.00117	CcSEcCtD
Pentosan Polysulfate—FGF4—IRS-related events triggered by IGF1R—IL6—acquired immunodeficiency syndrome	0.000796	0.00693	CbGpPWpGaD
Pentosan Polysulfate—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000794	0.00117	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.000793	0.00116	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000792	0.00116	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000791	0.00116	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00079	0.00116	CcSEcCtD
Pentosan Polysulfate—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000789	0.00116	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000789	0.00116	CcSEcCtD
Pentosan Polysulfate—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000785	0.00115	CcSEcCtD
Pentosan Polysulfate—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000785	0.00115	CcSEcCtD
Pentosan Polysulfate—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000785	0.00115	CcSEcCtD
Pentosan Polysulfate—FGF4—Disease—CCNT1—acquired immunodeficiency syndrome	0.000785	0.00683	CbGpPWpGaD
Pentosan Polysulfate—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000784	0.00115	CcSEcCtD
Pentosan Polysulfate—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000783	0.00115	CcSEcCtD
Pentosan Polysulfate—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.00078	0.00115	CcSEcCtD
Pentosan Polysulfate—Rash—Didanosine—acquired immunodeficiency syndrome	0.000778	0.00114	CcSEcCtD
Pentosan Polysulfate—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000778	0.00114	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000778	0.00114	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000778	0.00114	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000778	0.00114	CcSEcCtD
Pentosan Polysulfate—FGF4—IGF1R signaling cascade—IL6—acquired immunodeficiency syndrome	0.000775	0.00674	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Insulin receptor signalling cascade—IL6—acquired immunodeficiency syndrome	0.000775	0.00674	CbGpPWpGaD
Pentosan Polysulfate—Headache—Didanosine—acquired immunodeficiency syndrome	0.000773	0.00114	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000772	0.00113	CcSEcCtD
Pentosan Polysulfate—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.00077	0.00113	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000768	0.00113	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000767	0.00113	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000765	0.00112	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000763	0.00112	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000762	0.00112	CcSEcCtD
Pentosan Polysulfate—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000761	0.00112	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00076	0.00112	CcSEcCtD
Pentosan Polysulfate—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000758	0.00111	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000757	0.00111	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000756	0.00111	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000756	0.00111	CcSEcCtD
Pentosan Polysulfate—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000756	0.00111	CcSEcCtD
Pentosan Polysulfate—FGF2—Differentiation Pathway—IL6—acquired immunodeficiency syndrome	0.000755	0.00657	CbGpPWpGaD
Pentosan Polysulfate—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000753	0.00111	CcSEcCtD
Pentosan Polysulfate—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000753	0.00111	CcSEcCtD
Pentosan Polysulfate—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000747	0.0011	CcSEcCtD
Pentosan Polysulfate—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000747	0.0011	CcSEcCtD
Pentosan Polysulfate—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000746	0.0011	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000746	0.0011	CcSEcCtD
Pentosan Polysulfate—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000741	0.00109	CcSEcCtD
Pentosan Polysulfate—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.00074	0.00109	CcSEcCtD
Pentosan Polysulfate—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00074	0.00109	CcSEcCtD
Pentosan Polysulfate—FGF4—Immune System—ACTG1—acquired immunodeficiency syndrome	0.000737	0.00641	CbGpPWpGaD
Pentosan Polysulfate—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000736	0.00108	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000736	0.00108	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000735	0.00108	CcSEcCtD
Pentosan Polysulfate—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000735	0.00108	CcSEcCtD
Pentosan Polysulfate—FGF4—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	0.000734	0.00639	CbGpPWpGaD
Pentosan Polysulfate—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000733	0.00108	CcSEcCtD
Pentosan Polysulfate—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000733	0.00108	CcSEcCtD
Pentosan Polysulfate—FGF2—Innate Immune System—ACTG1—acquired immunodeficiency syndrome	0.000732	0.00637	CbGpPWpGaD
Pentosan Polysulfate—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.00073	0.00107	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000729	0.00107	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000727	0.00107	CcSEcCtD
Pentosan Polysulfate—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000727	0.00107	CcSEcCtD
Pentosan Polysulfate—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000724	0.00106	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000722	0.00106	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000721	0.00106	CcSEcCtD
Pentosan Polysulfate—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000718	0.00106	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000714	0.00105	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000714	0.00105	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000712	0.00105	CcSEcCtD
Pentosan Polysulfate—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000711	0.00104	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000709	0.00104	CcSEcCtD
Pentosan Polysulfate—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000709	0.00104	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000708	0.00104	CcSEcCtD
Pentosan Polysulfate—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000708	0.00104	CcSEcCtD
Pentosan Polysulfate—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000706	0.00104	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000703	0.00103	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.0007	0.00103	CcSEcCtD
Pentosan Polysulfate—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.0007	0.00103	CcSEcCtD
Pentosan Polysulfate—Rash—Nevirapine—acquired immunodeficiency syndrome	0.0007	0.00103	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000699	0.00103	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000698	0.00103	CcSEcCtD
Pentosan Polysulfate—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000698	0.00103	CcSEcCtD
Pentosan Polysulfate—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000697	0.00102	CcSEcCtD
Pentosan Polysulfate—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000695	0.00102	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000694	0.00102	CcSEcCtD
Pentosan Polysulfate—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000694	0.00102	CcSEcCtD
Pentosan Polysulfate—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000693	0.00102	CcSEcCtD
Pentosan Polysulfate—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.00069	0.00101	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000689	0.00101	CcSEcCtD
Pentosan Polysulfate—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000688	0.00101	CcSEcCtD
Pentosan Polysulfate—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000685	0.00101	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000685	0.00101	CcSEcCtD
Pentosan Polysulfate—FGF4—Adaptive Immune System—CD79A—acquired immunodeficiency syndrome	0.000684	0.00595	CbGpPWpGaD
Pentosan Polysulfate—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000684	0.001	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000683	0.001	CcSEcCtD
Pentosan Polysulfate—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000681	0.001	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000681	0.001	CcSEcCtD
Pentosan Polysulfate—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000678	0.000996	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000677	0.000995	CcSEcCtD
Pentosan Polysulfate—Rash—Stavudine—acquired immunodeficiency syndrome	0.000676	0.000993	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000675	0.000992	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000675	0.000991	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000674	0.00099	CcSEcCtD
Pentosan Polysulfate—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000674	0.00099	CcSEcCtD
Pentosan Polysulfate—Headache—Stavudine—acquired immunodeficiency syndrome	0.000671	0.000987	CcSEcCtD
Pentosan Polysulfate—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000671	0.000986	CcSEcCtD
Pentosan Polysulfate—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.00067	0.000984	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000669	0.000984	CcSEcCtD
Pentosan Polysulfate—Rash—Abacavir—acquired immunodeficiency syndrome	0.000666	0.000978	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000665	0.000977	CcSEcCtD
Pentosan Polysulfate—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000665	0.000977	CcSEcCtD
Pentosan Polysulfate—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000664	0.000976	CcSEcCtD
Pentosan Polysulfate—Headache—Abacavir—acquired immunodeficiency syndrome	0.000661	0.000972	CcSEcCtD
Pentosan Polysulfate—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000661	0.000971	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00066	0.00097	CcSEcCtD
Pentosan Polysulfate—FGF1—Innate Immune System—MBL2—acquired immunodeficiency syndrome	0.00066	0.00574	CbGpPWpGaD
Pentosan Polysulfate—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000659	0.000969	CcSEcCtD
Pentosan Polysulfate—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000659	0.000968	CcSEcCtD
Pentosan Polysulfate—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000655	0.000963	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000651	0.000957	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.00065	0.000956	CcSEcCtD
Pentosan Polysulfate—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.00065	0.000956	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000647	0.000951	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000646	0.000949	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000645	0.000948	CcSEcCtD
Pentosan Polysulfate—FGF4—Signaling by Insulin receptor—IL6—acquired immunodeficiency syndrome	0.000644	0.0056	CbGpPWpGaD
Pentosan Polysulfate—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000643	0.000945	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.00064	0.000941	CcSEcCtD
Pentosan Polysulfate—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000639	0.000938	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000638	0.000938	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000638	0.000937	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000637	0.000937	CcSEcCtD
Pentosan Polysulfate—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000637	0.000935	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000635	0.000933	CcSEcCtD
Pentosan Polysulfate—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000634	0.000931	CcSEcCtD
Pentosan Polysulfate—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000631	0.000926	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.00063	0.000925	CcSEcCtD
Pentosan Polysulfate—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000627	0.000922	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000626	0.00092	CcSEcCtD
Pentosan Polysulfate—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000622	0.000914	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000621	0.000913	CcSEcCtD
Pentosan Polysulfate—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000619	0.00091	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000619	0.00091	CcSEcCtD
Pentosan Polysulfate—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000616	0.000905	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000614	0.000902	CcSEcCtD
Pentosan Polysulfate—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000613	0.000901	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000606	0.00089	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000606	0.00089	CcSEcCtD
Pentosan Polysulfate—FGF4—Immune System—MBL2—acquired immunodeficiency syndrome	0.000605	0.00527	CbGpPWpGaD
Pentosan Polysulfate—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000603	0.000886	CcSEcCtD
Pentosan Polysulfate—FGF2—Innate Immune System—MBL2—acquired immunodeficiency syndrome	0.000602	0.00524	CbGpPWpGaD
Pentosan Polysulfate—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000601	0.000884	CcSEcCtD
Pentosan Polysulfate—FGF2—MicroRNAs in cardiomyocyte hypertrophy—TNF—acquired immunodeficiency syndrome	0.000598	0.0052	CbGpPWpGaD
Pentosan Polysulfate—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000597	0.000877	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000597	0.000877	CcSEcCtD
Pentosan Polysulfate—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000596	0.000876	CcSEcCtD
Pentosan Polysulfate—FGF4—MAPK Signaling Pathway—TNF—acquired immunodeficiency syndrome	0.000593	0.00516	CbGpPWpGaD
Pentosan Polysulfate—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000593	0.000871	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000593	0.000871	CcSEcCtD
Pentosan Polysulfate—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000592	0.00087	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000592	0.00087	CcSEcCtD
Pentosan Polysulfate—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000587	0.000863	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000587	0.000862	CcSEcCtD
Pentosan Polysulfate—FGF1—Disease—APOBEC3G—acquired immunodeficiency syndrome	0.000586	0.0051	CbGpPWpGaD
Pentosan Polysulfate—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000585	0.00086	CcSEcCtD
Pentosan Polysulfate—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000584	0.000858	CcSEcCtD
Pentosan Polysulfate—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000579	0.000851	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000578	0.000849	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000577	0.000848	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000576	0.00501	CbGpPWpGaD
Pentosan Polysulfate—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000575	0.000845	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000574	0.000844	CcSEcCtD
Pentosan Polysulfate—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000573	0.000842	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000573	0.000841	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.00057	0.000838	CcSEcCtD
Pentosan Polysulfate—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000569	0.000836	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.00056	0.000823	CcSEcCtD
Pentosan Polysulfate—FGF4—Adaptive Immune System—CD40LG—acquired immunodeficiency syndrome	0.000558	0.00485	CbGpPWpGaD
Pentosan Polysulfate—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000554	0.000814	CcSEcCtD
Pentosan Polysulfate—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000554	0.000814	CcSEcCtD
Pentosan Polysulfate—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000553	0.000813	CcSEcCtD
Pentosan Polysulfate—FGF4—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	0.000552	0.00481	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—CD8A—acquired immunodeficiency syndrome	0.000551	0.0048	CbGpPWpGaD
Pentosan Polysulfate—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000551	0.00081	CcSEcCtD
Pentosan Polysulfate—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000551	0.000809	CcSEcCtD
Pentosan Polysulfate—FGF4—Signaling by SCF-KIT—IL6—acquired immunodeficiency syndrome	0.000551	0.00479	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000549	0.00478	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000549	0.00478	CbGpPWpGaD
Pentosan Polysulfate—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000548	0.000805	CcSEcCtD
Pentosan Polysulfate—Rash—Indinavir—acquired immunodeficiency syndrome	0.000546	0.000803	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000546	0.000802	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000544	0.000799	CcSEcCtD
Pentosan Polysulfate—Headache—Indinavir—acquired immunodeficiency syndrome	0.000543	0.000798	CcSEcCtD
Pentosan Polysulfate—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000541	0.000795	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000536	0.000787	CcSEcCtD
Pentosan Polysulfate—FGF2—Disease—APOBEC3G—acquired immunodeficiency syndrome	0.000534	0.00465	CbGpPWpGaD
Pentosan Polysulfate—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000534	0.000784	CcSEcCtD
Pentosan Polysulfate—FGF4—Adaptive Immune System—HLA-B—acquired immunodeficiency syndrome	0.000531	0.00462	CbGpPWpGaD
Pentosan Polysulfate—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000528	0.000776	CcSEcCtD
Pentosan Polysulfate—FGF4—Downstream signaling of activated FGFR—IL6—acquired immunodeficiency syndrome	0.000527	0.00459	CbGpPWpGaD
Pentosan Polysulfate—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000526	0.000772	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000525	0.00457	CbGpPWpGaD
Pentosan Polysulfate—FGF1—IRS-mediated signalling—IL6—acquired immunodeficiency syndrome	0.000524	0.00456	CbGpPWpGaD
Pentosan Polysulfate—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00052	0.000765	CcSEcCtD
Pentosan Polysulfate—FGF4—Signaling by ERBB4—IL6—acquired immunodeficiency syndrome	0.000519	0.00451	CbGpPWpGaD
Pentosan Polysulfate—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000518	0.000761	CcSEcCtD
Pentosan Polysulfate—FGF1—Innate Immune System—CCR2—acquired immunodeficiency syndrome	0.000517	0.0045	CbGpPWpGaD
Pentosan Polysulfate—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000516	0.000758	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000516	0.000758	CcSEcCtD
Pentosan Polysulfate—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000515	0.000756	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000514	0.000755	CcSEcCtD
Pentosan Polysulfate—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000513	0.000754	CcSEcCtD
Pentosan Polysulfate—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000512	0.000753	CcSEcCtD
Pentosan Polysulfate—FGF1—IRS-related events—IL6—acquired immunodeficiency syndrome	0.00051	0.00444	CbGpPWpGaD
Pentosan Polysulfate—FGF1—IRS-related events triggered by IGF1R—IL6—acquired immunodeficiency syndrome	0.000505	0.0044	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CCNT1—acquired immunodeficiency syndrome	0.000498	0.00433	CbGpPWpGaD
Pentosan Polysulfate—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000498	0.000732	CcSEcCtD
Pentosan Polysulfate—FGF4—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000497	0.00432	CbGpPWpGaD
Pentosan Polysulfate—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000496	0.000728	CcSEcCtD
Pentosan Polysulfate—FGF4—Downstream signal transduction—IL6—acquired immunodeficiency syndrome	0.000495	0.00431	CbGpPWpGaD
Pentosan Polysulfate—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000494	0.000726	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000493	0.000725	CcSEcCtD
Pentosan Polysulfate—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000493	0.000725	CcSEcCtD
Pentosan Polysulfate—FGF4—Signaling by FGFR—IL6—acquired immunodeficiency syndrome	0.000493	0.00429	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Insulin receptor signalling cascade—IL6—acquired immunodeficiency syndrome	0.000492	0.00428	CbGpPWpGaD
Pentosan Polysulfate—FGF1—IGF1R signaling cascade—IL6—acquired immunodeficiency syndrome	0.000492	0.00428	CbGpPWpGaD
Pentosan Polysulfate—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000491	0.000721	CcSEcCtD
Pentosan Polysulfate—FGF4—Signaling by ERBB2—IL6—acquired immunodeficiency syndrome	0.00049	0.00427	CbGpPWpGaD
Pentosan Polysulfate—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.00049	0.00072	CcSEcCtD
Pentosan Polysulfate—FGF4—DAP12 signaling—IL6—acquired immunodeficiency syndrome	0.000488	0.00425	CbGpPWpGaD
Pentosan Polysulfate—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000486	0.000714	CcSEcCtD
Pentosan Polysulfate—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000479	0.000704	CcSEcCtD
Pentosan Polysulfate—FGF2—IRS-mediated signalling—IL6—acquired immunodeficiency syndrome	0.000478	0.00416	CbGpPWpGaD
Pentosan Polysulfate—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000477	0.000701	CcSEcCtD
Pentosan Polysulfate—FGF4—Immune System—CCR2—acquired immunodeficiency syndrome	0.000475	0.00413	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—CCR2—acquired immunodeficiency syndrome	0.000472	0.00411	CbGpPWpGaD
Pentosan Polysulfate—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000471	0.000691	CcSEcCtD
Pentosan Polysulfate—FGF1—Immune System—ACTG1—acquired immunodeficiency syndrome	0.000468	0.00407	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	0.000466	0.00405	CbGpPWpGaD
Pentosan Polysulfate—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000465	0.000684	CcSEcCtD
Pentosan Polysulfate—FGF2—IRS-related events—IL6—acquired immunodeficiency syndrome	0.000465	0.00405	CbGpPWpGaD
Pentosan Polysulfate—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000461	0.000677	CcSEcCtD
Pentosan Polysulfate—FGF2—IRS-related events triggered by IGF1R—IL6—acquired immunodeficiency syndrome	0.000461	0.00401	CbGpPWpGaD
Pentosan Polysulfate—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000461	0.000677	CcSEcCtD
Pentosan Polysulfate—FGF4—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	0.000459	0.004	CbGpPWpGaD
Pentosan Polysulfate—FGF4—DAP12 interactions—IL6—acquired immunodeficiency syndrome	0.000459	0.004	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	0.000459	0.004	CbGpPWpGaD
Pentosan Polysulfate—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000457	0.000671	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000456	0.00067	CcSEcCtD
Pentosan Polysulfate—FGF4—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	0.000455	0.00396	CbGpPWpGaD
Pentosan Polysulfate—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000455	0.000669	CcSEcCtD
Pentosan Polysulfate—FGF2—Disease—CCNT1—acquired immunodeficiency syndrome	0.000454	0.00395	CbGpPWpGaD
Pentosan Polysulfate—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000454	0.000667	CcSEcCtD
Pentosan Polysulfate—FGF4—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	0.000451	0.00393	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	0.000449	0.00391	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Insulin receptor signalling cascade—IL6—acquired immunodeficiency syndrome	0.000449	0.0039	CbGpPWpGaD
Pentosan Polysulfate—FGF2—IGF1R signaling cascade—IL6—acquired immunodeficiency syndrome	0.000449	0.0039	CbGpPWpGaD
Pentosan Polysulfate—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000443	0.000651	CcSEcCtD
Pentosan Polysulfate—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.00044	0.000646	CcSEcCtD
Pentosan Polysulfate—Rash—Saquinavir—acquired immunodeficiency syndrome	0.00044	0.000646	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000439	0.000645	CcSEcCtD
Pentosan Polysulfate—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000437	0.000642	CcSEcCtD
Pentosan Polysulfate—FGF1—Adaptive Immune System—CD79A—acquired immunodeficiency syndrome	0.000434	0.00378	CbGpPWpGaD
Pentosan Polysulfate—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00043	0.000632	CcSEcCtD
Pentosan Polysulfate—FGF4—Immune System—IFNA1—acquired immunodeficiency syndrome	0.000427	0.00372	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—ACTG1—acquired immunodeficiency syndrome	0.000426	0.00371	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	0.000425	0.0037	CbGpPWpGaD
Pentosan Polysulfate—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000423	0.000621	CcSEcCtD
Pentosan Polysulfate—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000419	0.000616	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000419	0.000616	CcSEcCtD
Pentosan Polysulfate—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000417	0.000612	CcSEcCtD
Pentosan Polysulfate—FGF4—Immune System—CD79A—acquired immunodeficiency syndrome	0.000415	0.00361	CbGpPWpGaD
Pentosan Polysulfate—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000414	0.000608	CcSEcCtD
Pentosan Polysulfate—FGF4—Disease—CXCR4—acquired immunodeficiency syndrome	0.000412	0.00359	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by Insulin receptor—IL6—acquired immunodeficiency syndrome	0.000409	0.00356	CbGpPWpGaD
Pentosan Polysulfate—FGF4—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	0.000407	0.00354	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—CD79A—acquired immunodeficiency syndrome	0.000396	0.00345	CbGpPWpGaD
Pentosan Polysulfate—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000395	0.00058	CcSEcCtD
Pentosan Polysulfate—FGF1—Immune System—MBL2—acquired immunodeficiency syndrome	0.000384	0.00334	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by Insulin receptor—IL6—acquired immunodeficiency syndrome	0.000373	0.00324	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—CD40LG—acquired immunodeficiency syndrome	0.000354	0.00308	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	0.000351	0.00305	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—MBL2—acquired immunodeficiency syndrome	0.00035	0.00305	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—CD8A—acquired immunodeficiency syndrome	0.00035	0.00305	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by SCF-KIT—IL6—acquired immunodeficiency syndrome	0.00035	0.00304	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000349	0.00303	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000349	0.00303	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	0.00034	0.00296	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000339	0.00295	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—CD40LG—acquired immunodeficiency syndrome	0.000338	0.00294	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—HLA-B—acquired immunodeficiency syndrome	0.000337	0.00293	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—CSF2—acquired immunodeficiency syndrome	0.000335	0.00291	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—CD8A—acquired immunodeficiency syndrome	0.000335	0.00291	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signaling of activated FGFR—IL6—acquired immunodeficiency syndrome	0.000334	0.00291	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—CD4—acquired immunodeficiency syndrome	0.00033	0.00287	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by ERBB4—IL6—acquired immunodeficiency syndrome	0.000329	0.00286	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—CD40LG—acquired immunodeficiency syndrome	0.000323	0.00281	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—HLA-B—acquired immunodeficiency syndrome	0.000322	0.0028	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	0.00032	0.00278	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—CD8A—acquired immunodeficiency syndrome	0.000319	0.00278	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by SCF-KIT—IL6—acquired immunodeficiency syndrome	0.000319	0.00277	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000318	0.00277	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000318	0.00277	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	0.000317	0.00276	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000315	0.00274	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signal transduction—IL6—acquired immunodeficiency syndrome	0.000314	0.00274	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by FGFR—IL6—acquired immunodeficiency syndrome	0.000313	0.00272	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by NGF—IL6—acquired immunodeficiency syndrome	0.000313	0.00272	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by ERBB2—IL6—acquired immunodeficiency syndrome	0.000311	0.00271	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	0.00031	0.0027	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 signaling—IL6—acquired immunodeficiency syndrome	0.00031	0.0027	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—HLA-B—acquired immunodeficiency syndrome	0.000307	0.00267	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000307	0.00267	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signaling of activated FGFR—IL6—acquired immunodeficiency syndrome	0.000305	0.00265	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CCR2—acquired immunodeficiency syndrome	0.000301	0.00262	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by ERBB4—IL6—acquired immunodeficiency syndrome	0.0003	0.00261	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	0.000291	0.00254	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 interactions—IL6—acquired immunodeficiency syndrome	0.000291	0.00254	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	0.000291	0.00254	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	0.000289	0.00251	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000289	0.00251	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000289	0.00251	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000288	0.0025	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signal transduction—IL6—acquired immunodeficiency syndrome	0.000287	0.0025	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	0.000286	0.00249	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR—IL6—acquired immunodeficiency syndrome	0.000285	0.00248	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	0.000285	0.00248	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by ERBB2—IL6—acquired immunodeficiency syndrome	0.000284	0.00247	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 signaling—IL6—acquired immunodeficiency syndrome	0.000282	0.00246	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—CCR5—acquired immunodeficiency syndrome	0.000282	0.00246	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CCR2—acquired immunodeficiency syndrome	0.000275	0.00239	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IFNA1—acquired immunodeficiency syndrome	0.000271	0.00236	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	0.000266	0.00231	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 interactions—IL6—acquired immunodeficiency syndrome	0.000266	0.00231	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	0.000266	0.00231	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CD79A—acquired immunodeficiency syndrome	0.000263	0.00229	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	0.000263	0.00229	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CXCR4—acquired immunodeficiency syndrome	0.000262	0.00228	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	0.000261	0.00227	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	0.00026	0.00226	CbGpPWpGaD
Pentosan Polysulfate—FGF1—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	0.000258	0.00225	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IFNA1—acquired immunodeficiency syndrome	0.000247	0.00215	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CD79A—acquired immunodeficiency syndrome	0.00024	0.00209	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CXCR4—acquired immunodeficiency syndrome	0.000239	0.00208	CbGpPWpGaD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	0.000235	0.00205	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.00022	0.00191	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000216	0.00188	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000215	0.00188	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CD40LG—acquired immunodeficiency syndrome	0.000215	0.00187	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CSF2—acquired immunodeficiency syndrome	0.000212	0.00185	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CD8A—acquired immunodeficiency syndrome	0.000212	0.00185	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—CD4—acquired immunodeficiency syndrome	0.000209	0.00182	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—HLA-B—acquired immunodeficiency syndrome	0.000204	0.00178	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	0.000201	0.00175	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—IFNG—acquired immunodeficiency syndrome	0.000199	0.00173	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—IL6—acquired immunodeficiency syndrome	0.000199	0.00173	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000198	0.00172	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000196	0.00171	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CD40LG—acquired immunodeficiency syndrome	0.000196	0.0017	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000195	0.0017	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CSF2—acquired immunodeficiency syndrome	0.000194	0.00169	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CD8A—acquired immunodeficiency syndrome	0.000194	0.00169	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—CD4—acquired immunodeficiency syndrome	0.000192	0.00167	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—CD4—acquired immunodeficiency syndrome	0.000191	0.00166	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—HLA-B—acquired immunodeficiency syndrome	0.000186	0.00162	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	0.000183	0.0016	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000183	0.00159	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000183	0.00159	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—IL6—acquired immunodeficiency syndrome	0.000181	0.00158	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CCR5—acquired immunodeficiency syndrome	0.000179	0.00156	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—IL6—acquired immunodeficiency syndrome	0.000178	0.00155	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000178	0.00155	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—CD4—acquired immunodeficiency syndrome	0.000177	0.00154	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—IL2—acquired immunodeficiency syndrome	0.000177	0.00154	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000167	0.00145	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000167	0.00145	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CCR5—acquired immunodeficiency syndrome	0.000163	0.00142	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—TNF—acquired immunodeficiency syndrome	0.000145	0.00126	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000139	0.00121	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000137	0.00119	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000127	0.00111	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IFNG—acquired immunodeficiency syndrome	0.000126	0.0011	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000126	0.00109	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000125	0.00109	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CD4—acquired immunodeficiency syndrome	0.000122	0.00106	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—IL6—acquired immunodeficiency syndrome	0.000117	0.00102	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IFNG—acquired immunodeficiency syndrome	0.000115	0.001	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000114	0.000996	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000114	0.000995	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—IL6—acquired immunodeficiency syndrome	0.000113	0.000985	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CD4—acquired immunodeficiency syndrome	0.000113	0.00098	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IL2—acquired immunodeficiency syndrome	0.000112	0.000977	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CD4—acquired immunodeficiency syndrome	0.000111	0.000968	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—IL6—acquired immunodeficiency syndrome	0.000104	0.000904	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—IL6—acquired immunodeficiency syndrome	0.000103	0.000899	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CD4—acquired immunodeficiency syndrome	0.000103	0.000894	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL2—acquired immunodeficiency syndrome	0.000102	0.00089	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—IL6—acquired immunodeficiency syndrome	9.59e-05	0.000835	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.25e-05	0.000631	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.72e-05	0.000585	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.62e-05	0.000576	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IL6—acquired immunodeficiency syndrome	6.6e-05	0.000574	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—IL6—acquired immunodeficiency syndrome	6.09e-05	0.00053	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL6—acquired immunodeficiency syndrome	6.01e-05	0.000523	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—IL6—acquired immunodeficiency syndrome	5.55e-05	0.000483	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.26e-05	0.000371	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.89e-05	0.000338	CbGpPWpGaD
